Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

A randomized trial on sodium reduction in two developing countries

Journal of Human Hypertension volume 19, pages 55–60 (2005)Cite this article

Abstract

Hypertension remains the most common cardiovascular risk factor in developing countries, yet the majority of patients have no access to pharmacological therapy. Population-wide preventive strategies, such as salt restriction, are an attractive alternative, but experience in resource-poor settings is limited. To address this question, we conducted a randomized crossover study of salt restriction in adults living in Nigeria and Jamaica in order to estimate the mean blood pressure (BP) response. After a 4-week run-in period to determine willingness to adhere to a low-salt diet, 56 Jamaicans and 58 Nigerians completed an 8-week crossover study of low-salt and high-salt intake. Baseline BPs were in the normotensive range (systolic=125 mmHg in Jamaica, 114 mmHg in Nigeria). Baseline urinary sodium excretion was 86.8 and 125.6 mEq/day in Nigeria and Jamaica, respectively. The mean difference between urinary sodium excretion at baseline and at the end of the 3-week low-sodium phase was 33.6 mEq/day in Nigeria and 57.5 mEq/day in Jamaica. During the high-sodium phase, mean change in urinary sodium excretion from baseline to week 3 was 35.0 and 5.5 mEq/day in Nigeria and Jamaica, respectively. The mean change in systolic BP (‘high’ vs ‘low’ sodium phase) was approximately 5 mmHg in both groups. This study suggests that the efficacy of sodium reduction in developing countries equals those noted in more affluent cultures. If promoted on a wide scale, sodium reduction could be used to treat persons with established hypertension, and more importantly, to prevent age-related increases in BP in poor communities.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  1. Institute of Medicine. Control of cardiovascular diseases in developing countries: Research, development, and institutional strengthening. National Academy Press. http://www.nap.edu/books/0309061377/html/index.html 1998.

  2. World Health Organization. The World Health Report, 2002. Geneva, Switzerland, http://www.who.int/whr/2002.

  3. Cappuccio FP et al. Double-blind randomised trial of modest salt restriction in older people. Lancet 1997; 350: 850–854.

    Article  CAS  Google Scholar 

  4. Svetkey LP et al. The DASH diet, sodium intake and blood pressure trial (DASH-sodium): rationale and design. DASH-Sodium Collaborative Research Group. J Am Diet Assoc 1999; 99: S96–S104.

    Article  CAS  Google Scholar 

  5. Vollmer WM et al. Effects of diet and sodium intake on blood pressure: subgroup analysis of the DASH-sodium trial. Ann Intern Med 2001; 135: 1019–1028.

    Article  CAS  Google Scholar 

  6. Law MR, Frost CD, Wald NJ . By how much does dietary salt reduction lower blood pressure? III—Analysis of data from trials of salt reduction. BMJ 1991; 302: 819–824.

    Article  CAS  Google Scholar 

  7. Kaufman JS et al. Obesity and hypertension prevalence in populations of African origin. The Investigators of the International Collaborative Study on Hypertension in Blacks. Epidemiology 1996; 7: 398–405.

    Article  CAS  Google Scholar 

  8. Adeyemo A et al. The feasibility of implementing a dietary sodium reduction intervention among free-living normotensive individuals in southwest Nigeria. Ethn Dis 2002; 12: 207–212.

    PubMed  Google Scholar 

  9. Ataman SL et al. Standardization of blood pressure measurement in an international comparative study. J Clin Epidemiol 1996; 49: 869–877.

    Article  CAS  Google Scholar 

  10. Brown H, Prescott R . Applied Mixed Models in Medicine. John Wiley and Sons, Ltd.: Chichester, 2001.

    Google Scholar 

  11. Cooper R et al. The prevalence of hypertension in seven populations of west African origin. Am J Public Health 1997; 87: 160–168.

    Article  CAS  Google Scholar 

  12. Hurwitz S et al. Controlled analysis of blood pressure sensitivity to sodium intake: interactions with hypertension type. J Hypertens 2003; 21: 951–959.

    Article  CAS  Google Scholar 

  13. Grim CE et al. Racial differences in blood pressure in Evans County, Georgia: relationship to sodium and potassium intake and plasma renin activity. J Chronic Dis 1980; 33: 87–94.

    Article  CAS  Google Scholar 

  14. Dai WS, Kuller LH, Miller G . Arterial blood pressure and urinary electrolytes. J Chronic Dis 1984; 37: 75–84.

    Article  CAS  Google Scholar 

  15. Watson RL et al. Urinary electrolytes, body weight, and blood pressure. Pooled cross-sectional results among four groups of adolescent females. Hypertension 1980; 2: 93–98.

    Article  CAS  Google Scholar 

  16. Tobian L . The Volhard lecture. Potassium and sodium in hypertension. J Hypertens Suppl 1988; 6: S12–S24.

    Article  CAS  Google Scholar 

  17. Tobian L . Dietary sodium chloride and potassium have effects on the pathophysiology of hypertension in humans and animals. Am J Clin Nutr 1997; 65: 606S–611S.

    Article  CAS  Google Scholar 

  18. Gallen IW et al. On the mechanism of the effects of potassium restriction on blood pressure and renal sodium retention. Am J Kidney Dis 1998; 31: 19–27.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Tropical Medical Research Institute, University of the West Indies, Kingston, Jamaica

    T Forrester, S Soarres-Wynter, L Sargent, F Bennett & R Wilks

  2. Department of Pediatrics, University College Hospital, University of Ibadan, Ibadan, Nigeria

    A Adeyemo

  3. Department of Preventive Medicine and Epidemiology, Loyola University Medical Center, Maywood, IL, USA

    A Luke, E Prewitt, H Kramer & R S Cooper

Authors
  1. T Forrester
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A Adeyemo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S Soarres-Wynter
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. L Sargent
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. F Bennett
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. R Wilks
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. A Luke
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. E Prewitt
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. H Kramer
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. R S Cooper
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R S Cooper.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Forrester, T., Adeyemo, A., Soarres-Wynter, S. et al. A randomized trial on sodium reduction in two developing countries. J Hum Hypertens 19, 55–60 (2005). https://doi.org/10.1038/sj.jhh.1001782

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1001782

Keywords

This article is cited by

Search

Advanced search

Quick links